Your Lipid Panel Is Always Abnormal. Your Genes May Be Why.

APOE encodes apolipoprotein E, a protein that attaches to cholesterol particles and directs them through your bloodstream to cells that need them. Your liver uses APOE to package cholesterol into lipoproteins, and your cells use APOE receptors to grab those particles from the blood. It’s the traffic controller of your lipid system.

You have two copies of APOE, and they come in three variants: e2, e3, and e4. Roughly 25% of people of European ancestry carry at least one e4 allele. If you have the e4 variant, your cells don’t clear LDL from your bloodstream as efficiently as they should. E4 carriers tend to have higher total cholesterol and LDL levels, even on identical diets. E2 carriers, by contrast, typically have lower cholesterol levels overall.

This plays out in your bloodwork as persistently elevated LDL despite diet changes, and in your body as a higher baseline cardiovascular risk. If you have e4 and your lipid panel is abnormal, you’re not failing at diet; your cells simply aren’t grabbing LDL particles from your blood as effectively as someone with e3 or e2.

PCSK9 encodes a protein that your liver uses to demolish LDL receptors on the surface of liver cells. Think of PCSK9 as a cleanup crew; it removes old or excess receptors so your liver doesn’t overabsorb LDL. But if your PCSK9 gene has a gain-of-function variant, your cleanup crew works overtime.

Gain-of-function PCSK9 variants are carried by roughly 1-3% of the general population, but they have an outsized effect. When your PCSK9 is overactive, it destroys LDL receptors faster than your liver can make new ones, so your blood accumulates LDL particles. Your LDL stays high no matter how much fiber you eat or how many miles you run. Standard statins work by telling your liver to make more LDL receptors, but if PCSK9 is destroying them, you’re fighting a losing battle.

You experience this as an LDL level that refuses to drop below 100 or 120 even on a statin, a family history of early heart disease, or xanthomas (cholesterol deposits on your skin or tendons). Your doctor keeps raising your statin dose, and your LDL barely budges.

LDLR encodes the LDL receptor itself, the protein on your liver cell surface that grabs LDL particles from your blood and brings them inside for processing. When your receptors work normally, they clear LDL efficiently. When they don’t, LDL accumulates in your bloodstream.

LDLR mutations cause familial hypercholesterolemia, and there are over 1,000 known pathogenic variants. This condition affects roughly 1 in 300 people in the general population. If you carry a pathogenic LDLR variant, your liver can’t clear LDL from your blood efficiently, leading to LDL levels that are often 2 to 3 times higher than normal. Diet, exercise, and standard statins help, but typically don’t normalize your numbers.

You experience this as LDL that has been high since childhood, a family history of early heart attacks, possible corneal arcus (a white ring around your eyes), or tendon xanthomas. Your lipid panel looks like someone who eats fast food daily, except you don’t. Multiple doctors have been puzzled by your numbers.

APOB is the structural backbone of LDL particles. Your liver wraps cholesterol in a coat of APOB, creating LDL particles that float through your bloodstream. Those particles only get cleared from your blood if APOB binds to LDL receptors on your liver cells. Without proper APOB function, the LDL receptor can’t grab the particle, no matter how many receptors you have.

APOB mutations that impair LDL receptor binding account for roughly 5% of familial hypercholesterolemia cases. The R3527Q variant is one of the most common. If your APOB is mutated, your LDL particles are invisible to your liver’s receptors. They circulate in your blood longer and accumulate at higher levels. Your liver can make all the receptors it wants, but they’re useless if APOB can’t dock.

You experience this as persistently elevated LDL despite maximal statin doses, a family history of early cardiovascular disease in relatives who also have high cholesterol, and little improvement from diet or lifestyle changes. Your numbers feel immovable.

CETP encodes cholesteryl ester transfer protein, which transfers protective HDL cholesterol onto LDL particles in exchange for triglycerides. This exchange is part of normal lipid metabolism, but when CETP is overactive, it can lower your protective HDL and shift your particle composition toward denser, more atherogenic LDL.

CETP variants like TaqIB and I405V are carried by roughly 40% of the population. If you have a variant that reduces CETP activity, your HDL stays higher and your LDL particle composition may shift, but the picture is complex: higher HDL can be protective, but altered LDL particle sizes may increase cardiovascular risk in some people. Some CETP variants are associated with longer lifespan in certain populations; others correlate with worse outcomes.

You experience this as an HDL-to-LDL ratio that doesn’t match typical cholesterol patterns, or HDL that stays stubbornly low despite exercise and weight loss. Your ‘good’ cholesterol won’t budge, or your LDL particle size is consistently small and dense on advanced lipid testing.

LPA encodes lipoprotein(a), a particle that looks like LDL but carries additional clotting risk on top of its cholesterol cargo. Your LPA level is almost entirely genetically determined, with diet and lifestyle playing almost no role. It’s one of the few truly heritable lipid traits.

Roughly 20% of the population has genetically elevated Lp(a), sometimes extremely high (above 50 mg/dL). If your LPA is genetically elevated, you’re carrying an independent risk factor for both heart disease and stroke, regardless of your LDL or HDL numbers. High Lp(a) is a stronger predictor of cardiovascular events in some studies than LDL itself. And standard statins don’t lower Lp(a) at all.

You experience this as a lipid panel that includes a high Lp(a) result (often reported separately), family history of early heart attacks in relatives with normal cholesterol, or a sense that your cardiovascular risk is higher than your LDL alone would suggest. Your doctor may have dismissed this number as ‘not much we can do about it’ because, until recently, that was true.